Здоровье

Swiss drugmaker Novartis on Tuesday raised its 2024 profit forecast for the third time amid greater use of its prescription drugs such as psoriasis and

Sun Pharmaceuticals, India’s largest drugmaker by revenue, reported second-quarter profit above analysts’ estimates, helped by higher demand for its speciality drugs used to treat rare

French drugmaker Sanofi posted stronger third-quarter profit growth than analysts expected, helped by an earlier-than-expected start to the vaccination season. The company’s quarterly operating income,

Pfizer’s quarterly financial report released on Tuesday coincided with a critical moment for the US drugmaker and its CEO, as activist hedge fund Starboard Value

French drugmaker Sanofi on Friday posted stronger third-quarter profit growth than analysts expected, helped by an earlier-than-expected start to the vaccination season.

The number of people infected by an E. coli outbreak linked to McDonald’s the U.S. Food and Drug Administration said Friday that the number of

The US Food and Drug Administration has approved Iterum Therapeutics The health regulator on Friday said the oral antibiotic is intended to treat certain types

On Tuesday, Pfizer appointed the former CEO of Vanguard, the pharmaceutical giant’s biggest investor, to its board as it faced pressure from activist hedge fund

Johnson & Johnson jurors ruled Tuesday that the company must pay $15 million to a Connecticut resident who claims he developed mesothelioma, a rare form

British drugmaker GlaxoSmithKline sued Moderna in a US federal court in Delaware, accusing the company of infringing GSK’s patent rights to GSK’s information RNA technology